Question 1

What is XORTX Therapeutics?

Accepted Answer

XORTX Therapeutics is a Company.

Question 2

How often does XORTX Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was XORTX Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 12, 2026.

Question 4

When was XORTX Therapeutics last mentioned in news?

Accepted Answer

Last active on Jul 31, 2026.

Question 5

What is XORTX Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 8 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is XORTX Therapeutics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving XORTX Therapeutics?

Accepted Answer

XORTX Delists from TSX Venture (Jun 12, 2026, 6 articles).

Question 8

How did the "XORTX Delists from TSX Venture" event impact XORTX Therapeutics?

Accepted Answer

XORTX Therapeutics Inc. is voluntarily delisting its common shares from the TSX Venture Exchange to reduce costs and administrative burden, aiming to optimize financing and focus on its XRx-026 program for gout treatment. This move is expected to improve its operational efficiency and long-term shareholder value.

Question 9

How did the "XORTX Director Anthony Giovinazzo Resigns" event impact XORTX Therapeutics?

Accepted Answer

XORTX loses its board chairman, a minor governance change. The company continues its clinical programs without disruption.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.